← Eichor
Condition: High Risk Hpv Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: High Risk Hpv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT05918510
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
NA · 8 location(s) · Universitair Ziekenhuis Brussel · NCT07029152
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Phase 1 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04131413
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical I
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT04057924
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
Phase 2 · 2 location(s) · Frantz Viral Therapeutics, LLC · NCT06206564
Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
Phase N/A · 1 location(s) · University of Pretoria · NCT02956031
HUC-MSC for Treatment of High-risk HPV Infection
Phase 1/Phase 2 · 1 location(s) · Shanghai East Hospital · NCT06610773
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk
NA · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT06052033
Screening Women With Prior HPV for Anal Neoplasia
NA · 3 location(s) · Icahn School of Medicine at Mount Sinai · NCT05217940
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06327568
Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.
NA · 1 location(s) · Centre Leon Berard · NCT07414719
Safety of Anal Curcumin
Phase 1 · 2 location(s) · Lisa Flowers · NCT06626230
Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
NA · 1 location(s) · Karolinska Institutet · NCT07275333
Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT05414032
Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of H
NA · 3 location(s) · ANRS, Emerging Infectious Diseases · NCT06522256
Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions
Phase 2 · 1 location(s) · Centre Oscar Lambret · NCT06658405
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
NA · 1 location(s) · University Hospital, Toulouse · NCT04901351
Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
Phase N/A · 20 location(s) · Fujian Maternity and Child Health Hospital · NCT05282095
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NA · 3 location(s) · Qurasense · NCT07281599
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · 15 location(s) · Catharina Ziekenhuis Eindhoven · NCT05405270
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HS
Phase 2 · 5 location(s) · Frantz Viral Therapeutics, LLC · NCT06075264
Anal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV
Phase N/A · 1 location(s) · Fondation Hôpital Saint-Joseph · NCT05566106
Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
NA · 1 location(s) · Dr. Danielle Vicus · NCT03061435
Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Phase N/A · 8 location(s) · International Vaccine Institute · NCT06129253
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Phase 2 · 7 location(s) · Frantz Viral Therapeutics, LLC · NCT04098744
Effect of Honey For CIN II
Phase 1/Phase 2 · 2 location(s) · Zuyderland Medisch Centrum · NCT06219018
Screening Strategies Among High-risk Populations for Anal Cancer
NA · 4 location(s) · Lisa Flowers · NCT06628570
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Phase N/A · 1 location(s) · University Hospital Tuebingen · NCT06291311
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.